Following approval by CRG, GMMMG, the Greater Manchester ICS Clinical Effectiveness and Governance Committee, and GM exec, the following updates have been made to the GMMMG formulary, and RAG list:

  • Metformin 1g immediate-release tablets have been added to the Do Not Prescribe list, criterion 2 (Products which are clinically effective but where more cost-effective products are available, including products that have been subject to excessive price inflation).

For more information on this decision see the May 2023 decision summary, available here.